Register
Login:
Share:
Email Facebook Twitter


Tech company Mporium delivers an outstanding set of Q1 results says CEO De Groot
IronRidge Resources CEO hails spectacular lithium project and money making potential for gold




Share Price Information for 4d Pharma Plc (DDDD)


Share Price: 122.50Bid: 120.00Ask: 125.00Change: 0.00 (0.00%)No Movement on 4d Pharma Plc
Spread: 5.00Spread as %: 4.17%Open: 109.00High: 0.00Low: 0.00Yesterday’s Close: 122.50

4d Pharma Plc Ord 0.25P

4d Pharma Plc is part of the Medicine and Biotech Research sector






Share Price SpacerPrice
122.50
Share Price SpacerBid
120.00
Share Price SpacerAsk
125.00
Share Price SpacerChange
0%0.00
Share Price SpacerVolume
0
Share Price SpacerOpen
109.00
Share Price SpacerHigh
0.00
Share Price SpacerLow
0.00
Share Price SpacerClose
122.50
Share Price SpacerCurrency
GBX


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 65.49m £80.23m 3,000

52 Week High 250.00 52 Week High Date 22-JUN-2018
52 Week Low 77.00 52 Week Low Date 11-MAR-2019

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
0 0 0 -3.900 -31.41 0.00 0.00


London South East Users info for 4d Pharma Plc




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

18-Apr-19
16:15:01
120.60
47
Sell* 
120.00
125.00
56.68
Trade Type:
Ordinary

18-Apr-19
15:43:15
120.60
1,500
Sell* 
120.00
125.00
1,809
Trade Type:
Ordinary

18-Apr-19
14:06:42
121.30
1,430
Sell* 
120.00
127.00
1,735
Trade Type:
Ordinary




View more 4d Pharma Plc trades >>

Directors Deals for 4d Pharma Plc (DDDD)
Trade DateActionNotifierPriceCurrencyAmountHolding
13-Mar-19Buy
Trade Notifier Information for 4D Pharma
Duncan Joseph Peyton held the position of CEO at 4D Pharma at the time of this trade.
 Duncan Joseph Peyton
92GBX6,7706343985
13-Mar-19Buy
Trade Notifier Information for 4D Pharma
Alexander James Stevenson held the position of Chief Scientific Officer at 4D Pharma at the time of this trade.
 Alexander James Stevenson
91.5GBX24,8966362138
12-Mar-19Buy
Trade Notifier Information for 4D Pharma
David Robert Norwood held the position of Non-Executive Chairman at 4D Pharma at the time of this trade.
 David Robert Norwood
82.36GBX23,7257103725
View more 4d Pharma Plc directors dealings >>


PotPot80
Posts: 314
Opinion:No Opinion
Price:117.00
RE: level 2
Thu 15:54
That would be great news.
barnetpeter
Posts: 1,167
Premium Chat Member
Opinion:No Opinion
Price:147.00
level 2
25 Mar '19
is very interesting. MM;s dont want to sell many but on the buy side will take plenty of stock.

Something here....maybe positive news or even an offer??
barnetpeter
Posts: 1,167
Premium Chat Member
Opinion:No Opinion
Price:147.00
up every day
25 Mar '19
since I bought these at 105p. Don't get it right so well that often.....
dusterinmong
Posts: 684
Opinion:No Opinion
Price:116.00
£2
20 Mar '19
Looks to be on the way with the fight news?

Research??
ResearchAnalyst1
Posts: 115
Opinion:Strong Buy
Price:108.50
Avarice
15 Mar '19
What’s the difference between insider dealing and insider knowledge? The former is illegal and the latter is legal. Simple.

Directors have insider knowledge at all times.

From the skeletons in the cupboard, to the progress in the lab, to the prospects far into the future, directors have a picture no one else can expect to see.

And when they start buying, look out for random purchase patterns – where the directors are buying lumps of shares in an attempt to make a material profit in the near term from a substantive rise in the company’s share price.

Simply put, the stock purchases should look contrived; that is, it should look like they’re scrapping together cash on the basis they just can’t resist it.

This is the narrative you are looking for – old fashion avarice.

It's all over this one.
View more share chat for 4d Pharma Plc (DDDD) >>







Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk











Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.